News
Genentech's Portal study shows Susvimo maintains vision and retinal drying in wet AMD patients over five years with biannual ...
TearCare is associated with greater health utility over time but also resulted in significant cost savings compared to CsA ...
FDA approval was based on phase 3 trials showing significant tear production increase as early as Day 1.
Raytone Biotech has successfully treated the first patient in its clinical trial of RTP-008 for the treatment of dry eye ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results